Richard Schulz

Cited by

	All	Since 2019
Citations	20873	4098
h-index	69	34
i10-index	156	92

1100

550

275

825

199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202477 166 214 258 376 380 393 390 429 399 436 452 526 577 634 655 745 775 763 881 940 1021 1062 979 850 809 689 715 686 631 790 724 648 616

Public access

View all

45 articles

17 articles

available

not available

Based on funding mandates

Co-authors

Grzegorz SawickiUniversity of SaskatchewanVerified email at usask.ca
Po-Yin CheungVerified email at ualberta.ca
Gary LopaschukProfessor, Pediatrics, Universit of AlbertaVerified email at ualberta.ca
Mohammad A.M Ali, B.Pharm, MSc, Ph...School of Pharmacy & Pharmaceutical Sciences SUNY Binghamton UniversityVerified email at binghamton.edu
Péter FerdinandySemmelweis University, Budapest; Pharmahungary Group, Szeged, HungaryVerified email at pharmahungary.com
Manoj M. LaluDepartment of Anesthesiology and Pain Medicine, Clinical Epidemiology Program, Regenerative MedicineVerified email at toh.ca
Woo Jung ChoSenior Scientist in Cell & Tissue Imaging Center at St. Jude Children’s Research HospitalVerified email at stjude.org
Tamás CsontUniversity of SzegedVerified email at med.u-szeged.hu
Ava ChowVerified email at ualberta.ca
Marek Witold RadomskiUniversity of Saskatchewan College of MedicineVerified email at usask.ca
Michele CastroProfessor Doutor Departamento de Farmacologia, Faculdade de Medicina de Ribeirão Preto, USPVerified email at fmrp.usp.br
Arulmozhi KandasamyResearch Scientist, University of AlbertaVerified email at ualberta.ca
Bryan CrawfordProfessor of BiologyVerified email at unb.ca
C CsonkaUniversity of szegedVerified email at med.u-szeged.hu
Wesam Bassiouni (Farag)Postdoctoral Fellow, University of AlbertaVerified email at ualberta.ca
Ahmed El-Yazbi, BPharm, PhD, BCPS,...Faculty of Pharmacy, Alexandria University and Faculty of Pharmacy, Alamein International UniversityVerified email at aiu.edu.eg
mieczyslaw wozniakprofesor medycyny laboratoryjnej, uniwersytet medyczny we WrocławiuVerified email at umed.wroc.pl
Eduardo SalasCSO, GendiagVerified email at gendiag.com
Zabed MahmudPostdoctoral Research Fellow, Department of Pediatrics, University of AlbertaVerified email at ualberta.ca
Henk GranzierProfessor of Cellular and Molecular Medicine, Physiology, Biomedical EngineeringVerified email at email.arizona.edu

Richard Schulz

Professor, Departments of Pediatrics & Pharmacology, University of Alberta, Edmonton Canada

Verified email at ualberta.ca

matrix metalloproteinases oxidative stress heart disease pharmacology physiology


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo DD Rees, RMJ Palmer, R Schulz, HF Hodson, S Moncada British journal of pharmacology 101 (3), 746-752, 1990	2416	1990
Induction and potential biological relevance of a Ca2+‐independent nitric oxide synthase in the myocardium R Schulz, E Nava, S Moncada British journal of pharmacology 105 (3), 575-580, 1992	763	1992
Nitric oxide, superoxide, and peroxynitrite in myocardial ischemia-reperfusion injury and preconditioning P Ferdinandy, R Schulz British Journal of Pharmacology 138, 532-543, 2003	663	2003
Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart PY Cheung, G Sawicki, M Wozniak, W Wang, MW Radomski, R Schulz Circulation 101 (15), 1833-1839, 2000	623	2000
Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo. S Moncada, DD Rees, R Schulz, RM Palmer Proceedings of the National Academy of Sciences 88 (6), 2166-2170, 1991	581	1991
Intracellular action of matrix metalloproteinase-2 accounts for acute myocardial ischemia and reperfusion injury W Wang, CJ Schulze, WL Suarez-Pinzon, JRB Dyck, G Sawicki, R Schulz Circulation 106 (12), 1543-1549, 2002	572	2002
Peroxynitrite is a major contributor to cytokine-induced myocardial contractile failure P Ferdinandy, H Danial, I Ambrus, RA Rothery, R Schulz Circulation research 87 (3), 241-247, 2000	572	2000
Isolated heart perfusion according to Langendorff—still viable in the new millennium M Skrzypiec-Spring, B Grotthus, A Szeląg, R Schulz Journal of pharmacological and toxicological methods 55 (2), 113-126, 2007	567	2007
Matrix metalloproteinase-2 and myocardial oxidative stress injury: beyond the matrix AD Kandasamy, AK Chow, MAM Ali, R Schulz Cardiovascular research 85 (3), 413-423, 2010	480	2010
Matrix metalloproteinase-2 and myocardial oxidative stress injury: beyond the matrix AD Kandasamy, AK Chow, MAM Ali, R Schulz Cardiovascular Research 85 (3), 413-423, 2010	480	2010
Generation of peroxynitrite contributes to ischemia-reperfusion injury in isolated rat hearts W Yasmin, KD Strynadka, R Schulz Cardiovascular research 33 (2), 422-432, 1997	437	1997
Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death IN Mungrue, R Gros, X You, A Pirani, A Azad, T Csont, R Schulz, J Butany, ... The Journal of clinical investigation 109 (6), 735-743, 2002	415	2002
Intracellular targets of matrix metalloproteinase-2 in cardiac disease: rationale and therapeutic approaches R Schulz Annu. Rev. Pharmacol. Toxicol. 47 (1), 211-242, 2007	371	2007
Acute actions and novel targets of matrix metalloproteinases in the heart and vasculature AK Chow, J Cena, R Schulz British journal of pharmacology 152 (2), 189-205, 2007	352	2007
Role of nitric oxide and cGMP in human septic serum-induced depression of cardiac myocyte contractility A Kumar, R Brar, P Wang, L Dee, G Skorupa, F Khadour, R Schulz, ... American Journal of Physiology-Regulatory, Integrative and Comparative …, 1999	340	1999
Characterization of 5′ AMP-activated protein kinase activity in the heart and its role in inhibiting acetyl-CoA carboxylase during reperfusion following ischemia N Kudo, JG Gillespie, L Kung, LA Witters, R Schulz, AS Clanachan, ... Biochimica et Biophysica Acta (BBA)-Lipids and Lipid Metabolism 1301 (1-2 …, 1996	333	1996
Degradation of myosin light chain in isolated rat hearts subjected to ischemia-reperfusion injury: a new intracellular target for matrix metalloproteinase-2 G Sawicki, H Leon, J Sawicka, M Sariahmetoglu, CJ Schulze, PG Scott, ... Circulation 112 (4), 544-552, 2005	315	2005
Cardiac efficiency is improved after ischemia by altering both the source and fate of protons B Liu, AS Clanachan, R Schulz, GD Lopaschuk Circulation research 79 (5), 940-948, 1996	313	1996
The role of nitric oxide in cardiac depression induced by interleukin‐1β and tumour necrosis factor‐α R Schulz, DL Panas, R Catena, S Moncada, PM Olley, GD Lopaschuk British journal of pharmacology 114 (1), 27-34, 1995	313	1995
Nitrosative stress and pharmacological modulation of heart failure P Pacher, R Schulz, L Liaudet, C Szabó Trends in pharmacological sciences 26 (6), 302-310, 2005	308	2005

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors